The present invention relates to the method of determining the risk of acute kidney injury comprising determining the amount of a marker selected from VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM or any combination thereof in a sample.
申请公布号
US8338096(B2)
申请公布日期
2012.12.25
申请号
US20090937716
申请日期
2009.04.15
申请人
OBERBAUER RAINER;KAINZ ALEXANDER;MAYER BERND;PERCO PAUL
发明人
OBERBAUER RAINER;KAINZ ALEXANDER;MAYER BERND;PERCO PAUL
